Adria's Mycobutin (rifabutin)
Executive Summary
Under its approved Treatment IND application, the company will not charge AIDS patients for the drug, which delays or prevents Mycobacterium avium complex ("The Pink Sheet" March 9, T&G-13). Distribution of rifabutin is being handled by PACT, a clinical consulting firm. Through an "800" telephone number for physicians, PACT will enroll eligible patients into the program and deliver a three-month supply for physicians to provide to patients. Adria said it has rifabutin ready for 5,000 patients. The company submitted a rolling NDA for the drug on Jan. 17.